FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

433127001: Trabectedin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2745741018 Trabectedin (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2767125015 Trabectedin en Synonym Active Entire term case insensitive SNOMED CT core module
2773269019 Ecteinascidin 743 en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trabectedin Is a Antineoplastic alkaloid false Inferred relationship Existential restriction modifier
Trabectedin Is a Alkaloid true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing trabectedin Has active ingredient True Trabectedin Inferred relationship Existential restriction modifier 1
Product containing trabectedin in parenteral dose form (medicinal product form) Has active ingredient True Trabectedin Inferred relationship Existential restriction modifier 1
Trabectedin Has active ingredient True Trabectedin Inferred relationship Existential restriction modifier 1
Product containing only trabectedin in parenteral dose form (medicinal product form) Has active ingredient True Trabectedin Inferred relationship Existential restriction modifier 1
Product containing precisely trabectedin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Trabectedin Inferred relationship Existential restriction modifier 1
Product containing precisely trabectedin 1 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Trabectedin Inferred relationship Existential restriction modifier 1
Product containing precisely trabectedin 250 microgram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Trabectedin Inferred relationship Existential restriction modifier 1
Product containing precisely trabectedin 250 microgram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Trabectedin Inferred relationship Existential restriction modifier 1
Trabectedin 1mg powder for solution for infusion vials Has active ingredient False Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 250microgram powder for solution for infusion vials Has active ingredient False Trabectedin Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Yondelis 1mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 1mg powder for solution for infusion vials Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Yondelis 1mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Yondelis 1mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) 1 vial Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 1mg powder for solution for infusion vials 1 vial Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 250microgram powder for solution for infusion vials 1 vial Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) 1 vial Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 250microgram powder for solution for infusion vials Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 250microgram powder for solution for infusion vials (Special Order) Has active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 250microgram powder for solution for infusion vials (Special Order) Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 1mg powder for solution for infusion vials (Special Order) Has active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 1mg powder for solution for infusion vials (Special Order) Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 250microgram powder for solution for infusion vials (Special Order) 1 vial Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier
Trabectedin 1mg powder for solution for infusion vials (Special Order) 1 vial Has specific active ingredient True Trabectedin Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start